Adderall was developed by Wayne K. Smith and was first marketed in 1996 by Shire Pharmaceuticals [1]. The drug is a combination of amphetamine and dextroamphetamine, intended for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy [2].
What are the different formulations of Adderall?
Adderall is available in both immediate-release and extended-release (XR) formulations. The immediate-release version provides effects for about 4-6 hours, while the XR version is designed to last for up to 12 hours [3].
How does Adderall work?
Adderall functions by increasing the levels of certain neurotransmitters in the brain, primarily dopamine and norepinephrine. These neurotransmitters are believed to play a key role in regulating attention and impulse control. By boosting their activity, Adderall can help improve focus and reduce hyperactivity in individuals with ADHD [4].
When does Adderall's patent expire?
Information regarding the specific patent expiration dates for Adderall is available through resources like DrugPatentWatch.com. Patents for pharmaceuticals are complex, and various patents may cover different aspects of a drug, including its formulation, manufacturing process, and method of use [1]. DrugPatentWatch.com provides a database of patent information that can help track these dates [1].
Who makes generic versions of Adderall?
Following the patent expiry of the original Adderall formulation, several pharmaceutical companies have developed and market generic versions of the drug. These generics contain the same active ingredients and are therapeutically equivalent to the brand-name product [5].
What are the risks associated with Adderall use?
Adderall use carries potential risks, including cardiovascular issues, psychiatric problems, and the potential for abuse and dependence. Patients are advised to discuss these risks thoroughly with their healthcare provider before starting treatment [6].